Erratum: 25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients (American Journal of Transplantation (2010) 10 (2287-2295) DOI: 10.1111/j.1600-6143.2010.03264.x);25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients

American Journal of Transplantation

Volumn 10, Issue 10, 2010, Pages 2287-2295

  Sawinski, D ^a   Uribarri, J ^a   Peace, D ^a   Yao, T ^a   Wauhop, P ^a   Trzcinka, P ^a   Ostrow, K ^a   Poggio, E D ^b   Heeger, P S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ELISPOT; kidney transplantation; T cell; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALLOANTIBODY; ANTIBODY; CALCITRIOL; GAMMA INTERFERON;

ALLOIMMUNITY; ARTICLE; BLOOD TRANSFUSION; CELLULAR IMMUNITY; DEMOGRAPHY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 77957201067     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03527.x     Document Type: Erratum

References (53)

1. Masopust D, Kaech SM, Wherry EJ, Ahmed R. The role of programming in memory T-cell development. Curr Opin Immunol 2004 16: 217 225. (Pubitemid 38328722)
2. Pearl JP, Parris J, Hale DA et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 5: 465 474. (Pubitemid 40313337)
3. Pantenburg B, Heinzel F, Das L, Heeger PS, Valujskikh A. T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol 2002 169: 3686 3693.
4. Valujskikh A, Pantenburg B, Heeger PS. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002 2: 501 509. (Pubitemid 36306868)
5. Augustine JJ, Siu DS, Clemente MJ, Schulak JA, Heeger PS, Hricik DE. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant 2005 5: 1971 1975.
6. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999 163: 2267 2275. (Pubitemid 29382237)
7. Hricik DE, Rodriguez V, Riley J et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003 3: 878 884. (Pubitemid 36827910)
8. Andree H, Nickel P, Nasiadko C et al. Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank. J Am Soc Nephrol 2006 17: 573 580.
9. Poggio ED, Augustine JJ, Clemente M et al. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007 83: 847 852. (Pubitemid 46682724)
10. Poggio ED, Clemente M, Hricik DE, Heeger PS. Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J Am Soc Nephrol 2006 17: 564 572.
11. Poggio ED, Clemente M, Riley J et al. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol 2004 15: 1952 1960. (Pubitemid 38822077)
12. Roddy M, Clemente M, Poggio ED et al. Heterogeneous alterations in human alloimmunity associated with immunization. Transplantation 2005 80: 297 302. (Pubitemid 41129956)
13. Adams JS, Hewison M. Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008 4: 80 90. (Pubitemid 351156900)
14. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009 94: 26 34.
15. Bikle DD. Vitamin D and the immune system: Role in protection against bacterial infection. Curr Opin Nephrol Hypertens 2008 17: 348 352.
16. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004 80 (6 Suppl 1717S 1720S.
17. Jean G, Terrat JC, Vanel T et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: Effects on mineral metabolism and bone markers. Nephrol Dial Transplant 2008 23: 3670 3676.
18. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985 134: 3032 3035. (Pubitemid 15249817)
19. Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984 74: 657 661. (Pubitemid 14054016)
20. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983 221: 1181 1183.
21. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: Effects on immunoglobulin production. J Immunol 1986 136: 2734 2740. (Pubitemid 16107171)
22. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol 2005 97: 93 101.
23. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006 5: 114 117. (Pubitemid 43129539)
24. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006 296: 2832 2838. (Pubitemid 44969183)
25. Podolsky DK. Inflammatory bowel disease (2). N Engl J Med 1991 325: 1008 1016.
26. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991 325: 928 937.
27. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991 100: 143 149.
28. Cutolo M, Otsa K. Review: Vitamin D, immunity and lupus. Lupus 2008 17: 6 10.
29. O'Herrin JK, Hullett DA, Heisey DM, Sollinger HW, Becker BN. A retrospective evaluation of 1,25-dihydroxyvitamin D(3) and its potential effects on renal allograft function. Am J Nephrol 2002 22: 515 520.
30. Bhalla AK, Amento EP, Serog B, Glimcher LH. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 1984 133: 1748 1754. (Pubitemid 14035260)
31. Clohisy DR, Bar-Shavit Z, Chappel JC, Teitelbaum SL. 1,25- Dihydroxyvitamin D3 modulates bone marrow macrophage precursor proliferation and differentiation. Up-regulation of the mannose receptor. J Biol Chem 1987 262: 15922 15929. (Pubitemid 17165192)
32. Hewison M, Freeman L, Hughes SV et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003 170: 5382 5390. (Pubitemid 36617823)
33. Penna G, Amuchastegui S, Giarratana N et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007 178: 145 153. (Pubitemid 46033595)
34. Piemonti L, Monti P, Sironi M et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000 164: 4443 4451. (Pubitemid 30238038)
35. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006 311: 1770 1773.
36. Zand MS, Bose A, Vo T et al. A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity. Am J Transplant 2005 5: 76 86. (Pubitemid 40095130)
37. Gebauer BS, Hricik DE, Atallah A et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002 2: 857 866. (Pubitemid 36306841)
38. Becker BN, Hullett DA, O'Herrin JK, Malin G, Sollinger HW, DeLuca H. Vitamin D as immunomodulatory therapy for kidney transplantation. Transplantation 2002 74: 1204 1206. (Pubitemid 35216124)
39. Hullett DA, Laeseke PF, Malin G, Nessel R, Sollinger HW, Becker BN. Prevention of chronic allograft nephropathy with vitamin D. Transpl Int 2005 18: 1175 1186. (Pubitemid 41726762)
40. Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007 72: 1004 1013. (Pubitemid 47530570)
41. Augustine JJ, Poggio ED, Clemente M et al. Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients. J Am Soc Nephrol 2007 18: 1602 1606. (Pubitemid 46729200)
42. Macedo C, Orkis EA, Popescu I et al. Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant 2009 9: 2057 2066.
43. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007 179: 1634 1647.
44. Griffin MD, Kumar R. Effects of 1alpha,25(OH)2D3 and its analogs on dendritic cell function. J Cell Biochem 2003 88: 323 326.
45. Manolagas SC, Provvedini DM, Tsoukas CD. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 1985 43: 113 122.
46. Helming L, Bose J, Ehrchen J et al. 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 2005 106: 4351 4358. (Pubitemid 41775947)
47. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 1995 125 (6 Suppl 1704S 1708S.
48. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001 167: 4974 4980. (Pubitemid 33009728)
49. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem 2003 88: 227 233. (Pubitemid 36119891)
50. Do JE, Kwon SY, Park S, Lee ES. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology (Oxford) 2008 47: 840 848. (Pubitemid 351796370)
51. Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003 111: 1887 1895.
52. Selin LK, Brehm MA, Naumov YN et al. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 2006 211: 164 181.
53. Steele DJ, Laufer TM, Smiley ST et al. Two levels of help for B cell alloantibody production. J Exp Med 1996 183: 699 703.